Header Logo

Connection

Anthonet Koen to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Anthonet Koen has written about Antibodies, Monoclonal, Humanized.
Anthonet Koen
Connection Strength
0,219
Antibodies, Monoclonal, Humanized
  1. Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children. Pediatrics. 2024 Oct 01; 154(4).
    View in: PubMed
    Score: 0,219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.